Preclinical toxicity testing is a critical phase in the drug development process that assesses the safety profile of a new compound before it can be tested in humans. This stage involves conducting animal studies and other laboratory experiments to evaluate the potential toxic effects of a drug candidate. The main goal is to ensure that the compound is safe and to identify any potential risks that might arise during clinical trials.
